Brookwood Investment Group »

Monte Rosa Therapeutics shares owned by Brookwood Investment Group

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Brookwood Investment Group from 13F filings

Historical chart of Brookwood Investment Group investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Brookwood Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Brookwood Investment Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $306k 20k 15.68

More positions owned by Brookwood Investment Group

NVIDIA Corporation (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Growth Etf (VUG)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Alphabet Cap Stk Cl A (GOOGL)
Morgan Stanley Etf Trust Eaton Vance Mort (EVMO)
Etf Ser Solutions Aptus Defined (DRSK)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)
Tidal Trust I Fundstrat Granny (GRNY)
Tcw Etf Trust Flexible Income (FLXR)
Pimco Etf Tr Multisector Bd (PYLD)

View all positions for Brookwood Investment Group

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Baker Bros. Advisors
TCG Crossover Management
Versant Venture Management
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
State Street Corporation
Aisling Capital Management
American Century Companies
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics